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The identiﬁcation of salvageable brain tissue is a major challenge at stroke presentation. Stan-
dard techniques used in this context, such as the perfusion–diffusion mismatch, remain
controversial. There is thus a need for new methods to help guide treatment. The potential
role of pH imaging in this context is currently being investigated. Intracellular pH varies as a
function of local perfusion, intracellular energy stores and time. Low pH triggers the production
of free radicals and affects the calcium balance of the cells, which may lead to apoptosis and cell
death. Thus, the characterization of pH dynamics may have predictive value for cell death after
stroke, particularly when combined with novel imaging techniques. Therefore, we have
extended an existing model of brain cellular metabolism to simulate the pH response of cells
to ischaemia. Simulation results for conditions of reduced cerebral blood ﬂow show good agree-
ment for the evolution of intracellular pH with previously reported measurements and
encourage the development of quantitative pH imaging to validate the predictive value of pH.
Keywords: predictive medicine; stroke; biochemical marker of stroke;
pH regulation; cellular metabolism
1. INTRODUCTION
1.1. Ischaemic stroke and its treatment
Based on studies from 2000 to 2008, the incidence rates
of stroke in high- and low- to middle-income countries
were 94 and 117 per 100 000 person-years, respectively
[1]. Total 2010 costs of stroke in the USA were $73.7
billion with indirect costs (i.e. lost productivity)
accounting for $25.5 billion [2]. Ischaemic stroke (85%
of all strokes) is caused by the thrombosis of a major
vessel supplying blood to a region of the brain. A short-
age of blood in the cerebral tissue leads to the reduction
of the level of metabolites such as oxygen and glucose.
This in turn causes the depletion of energy stores of
the affected cells and, if the shortage is signiﬁcant,
leads to their death. A review of cell physiology changes
and their timescales during ischaemia can be found in
Hossmann [3]. Most of the damage occurs within the
ﬁrst few hours after stroke [4]. Therefore, the main clini-
cal objective is to restore blood supply to the brain
within this timescale, either by removing the thrombus
mechanically through the insertion of a catheter in the
vascular network [5] or by dissolving the clot using
recombinant tissue plasminogen activator (rt-PA) [6].
A review of the development of recent interventional
techniques can be found in Nesbit et al. [7].
Unfortunately, there are drawbacks associated with
this second method. The injection of rt-PA can also
cause haemorrhage [8]. Out of 2775 patients randomly
allocated to rt-PA or placebo 5.9 per cent of the rt-PA
patients had a haemorrhage versus 1.1 per cent of con-
trols. To take that risk the clinician needs to be aware
of the amount and function of the brain tissue that can
potentially be saved by the restoration of circulation.
1.2. Current treatment planning and its
limitations
Currently, toassisttreatment decision-making perfusion
and diffusion images are used [9]. Perfusion-weighted
imaging quantiﬁes the deﬁcit of blood supply, while
diffusion-weighted imaging provides a measure of the
integrity of cell structure. The mismatch between the
two regions can be used to characterize salvageable
tissue [9]. However, there is little evidence it corresponds
to the tissue that is actually in danger (the penumbra)
[10,11]. This may lead clinicians to be over-cautious in
treatment planning [12]. Therefore, there is a need for a
new approach to complement current practice. There is
evidence that, in part, ischaemic damage is related to
pH [13]. A new magnetic resonance imaging (MRI) tech-
nique has recently been proposed for the assessment of
pH [14,15] and evolution from pH weighted imaging to
quantitative pH imaging is underway. However, as
MRI only provides a single time point in the evolution
of the ischaemic response, it is very important to under-
stand the dynamics of pH in both damaged and
vulnerable brain tissue. At this stage, this can be done
only using a mathematical model.
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I n t r a c e l l u l a rp Hi nt h eb r a i ni sm a i n t a i n e da ta p p r o x i -
mately 7.2 [16]. This parameter is strongly regulated by
active (ion pump transport) and passive (ion channel
transport, intracellular buffer solution) mechanisms [16].
During stroke, extrusion of CO2 from the cell is limited
by poor perfusion. Accumulation of CO2 in the intracellu-
lar space decreases the performance of the buffer solution
and contributes to the reduction of pH [17]. In addition,
the reduction of glucose and oxygen supply leads to the
depletion of glycogen and phosphocreatine (PCr; cellular
energy reserves), which increases the production of hydro-
gen ions. Overall, intracellular pH is dependent upon
local perfusion, intracellular energy reserves and time. A
pH threshold of 6.3–6.4 exists, beyond which cellular
pH-related damage is triggered [13].
pH regulates diverse cellular processes [18] and modu-
lates the activity of many enzymes and ion channels.
An extensive reference to these effects can be found in
Kaila & Ransom [13]. There are two main mechanisms
of acidosis-induced damage during ischaemia: free
radical formation and cell calcium metabolism. Free
radicals are activated when ischaemia is followed by
recirculation [19] and contribute to tissue damage [20]
andlowpHincreasestheirproduction[21–23].Ca
2þcon-
centration depends on the level of pH [24]. A change in
this parameter may trigger apoptosis, which can
occur for pH values of approximately 6.5 [25,26]. Other
acidosis-mediated damage mechanisms of neurons, glial
cells and microvessels are outlined in Kaila & Ransom
[13], Plum [27] and del Zoppo [28], respectively. It is
expected that a critical parameter determining the
magnitude of the pH drop is the amount of energy
reserves in the cell and in the blood [29] before stroke.
Therefore, knowledge of the pH dynamics, the pH
damage threshold and the capability of imaging brain
pH could provide clinically valuable information not
onlyaboutthetissuethatisalreadydeadonpresentation
but also about which brain tissue is most vulnerable to
further infarction.
1.4. Outline of the article
The remainder of this paper focuses on the modelling of
the key processes responsible for the production and
consumption of hydrogen ions and hence the regulation
of pH in brain cells post-stroke. These processes are
incorporated in a recently introduced model of brain
metabolism by Cloutier et al. ([30]; ﬁgure 1). Numerical
simulations are presented and compared with the
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Figure 1. Diagram representing the Cloutier et al. model [30] with, in red, the modiﬁcations allowing the computation of
pH dynamics in brain cells. Modiﬁcations include: the addition of a pH buffer represented by the word ‘buffer’, generation or
consumption of H
þ associated with ATPase, phospocreatine–creatine dynamics and LAC represented by ‘+1H
þ’, the addition
of seven ion channels or pumps associated with the regulation of pH represented by double ellipses on the left of the neurons
compartment and on the right of the astrocytes compartment. Red circles indicate modiﬁcations of CO2 or glycogen dynamics.
Red crosses indicate the suppression of elements related to glutamate dynamics.
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limitations of the model are discussed and conclusions
drawn about the accuracy and potential role of this
model in clinical practice.
2. METHODS
The pH dynamics model presented here incorporates
brain cell metabolism including H
þ production and con-
sumption, pH regulation and the model of increased
ATP consumption during stroke.
2.1. Modiﬁed metabolism model
Excessive production of H
þ ions in the cell after stroke is
o w i n gt ot w of a c t o r s :c o n s u m p t i o no fA T P ,g l u c o s eg l y c o -
gen and PCr stores, and a high concentration of CO2 [13].
To describe the dynamics of the consumption of energy
stores after stroke and thus the rate of change of pH,
we adapt an existing model of the brain metabolism
[30]. The model is composed of four compartments:
astrocytes, neurons, extracellular volume and capillary
vessels. ATP, glucose, glycogen, lactate (LAC), PCr, O2
and CO2 dynamics are all included.
The four compartment model is particularly suitable
for our approach as we want to understand the differ-
ences of the impact of hypoglycaemia and hypoxia on
the metabolism of both grey and white matter and to
look at the behaviour of astrocytes versus neurons. Fur-
thermore, the incorporation of the exchange of
metabolic products between cells and capillary vessels
allows more easily the fusion of the model with
patient-derived perfusion information.
The Cloutier et al. model was originally used to simu-
late glycogen breakdown in astrocytes during sensory
stimulation of freely moving rats. The model parameters
were calibrated using in vivo data of extracellular rat
brain glucose and LAC under different sensory stimuli.
Initial parameter values were taken from recent litera-
ture. Steady-state calibration ensured that the
consumption rates and ratio of glucose, LAC and
oxygen in the brain are correct. Validation with data
not used for the calibration of model parameters was sat-
isfactory. Equations, units and implementation of the
model reached curation status two according to CellML
(University of Auckland, Auckland, NZ) standards.
Transport of reactants through the capillary includes
LAC, O2,C O 2 and glucose. Transport through the
vessel wall depends on the concentration of reactants
in the vessel and in the extracellular space and the
blood ﬂow rate in the vessel. ATP in the cells is pro-
duced by either mitochondria fuelled with pyruvate
obtained through a six-step glycolysis of glucose, and
in the case of astrocytes also of glycogen if needed, or
through the transformation of PCr into creatine. Pyru-
vate can also be obtained from LAC. It is therefore
possible to simulate the astrocyte providing the
neuron with LAC to help with its metabolism in the
case of energy shortage. There are built-in mechanisms
for recharging the glycogen and PCr stores
when glucose is available at normal levels. ATP is
consumed for cell maintenance and for the running of
sodium–potassium pumps.
CO2 and LAC are the two metabolic products evac-
uated from the cells. Since the concentration of CO2
is simulated only in the capillary vessel it changes
instantly as a function of cerebral blood ﬂow (CBF)
and the activity of cell metabolism.
The model also includes glutamate dynamics to
couple metabolism and nervous stimulation. Since
these dynamics are not related to pH, these components
of the model are not considered.
As pH dynamics are closely coupled with metab-
olism, this model is adjusted here to simulate pH
dynamics under ischaemia. Based on the analysis in
Kaila & Ransom [13] we model H
þ ion production in
the brain by making the following four adjustments:
(i) baseline intracellular pH is set to 7.2; (ii) a decrease
in ATP concentration increases H
þ concentration by
the same amount; (iii) further H
þ is produced at the
same rate as LAC; and (iv) additional H
þ is produced
at the same rate as PCr concentration is increased in
the cell. This can be summarized by:
d½Hþ 
dt
¼ 
d½ATP 
dt
þ
d½LAC p
dt
þ
d½PCr 
dt
; ð2:1Þ
where d[LAC]p/dt stands for the rate of lactate
production in a cell.
We also make a small adjustment to activate glycogen
dynamics in the model. Following the analysis
in DiNuzzo et al. [31], we model glycogen dynamics
to be sensitive to small changes of AMP concentration in
the astrocyte. Glycogen phosphorylase is modelled by
vGP ¼ Vmax;GP 1 þ
Kh
m;AMP
½AMP 
h
 !  1
 
½GLY 
½GLY 0
  
; ð2:2Þ
whereVmax,GP ¼ 0.008 mM s
21,Km,AMP ¼ 0.016 mM s
21,
h ¼ 1.5 and [GLY]0 ¼ 2.5 mM is the baseline concen-
tration of glycogen. Glycogen synthase is modelled by
vGS ¼ Vmax;GS
½G6P a
Km;GS þ½ G6P a
  
: ð2:3Þ
Based on Kashiwaya et al. [32], Vmax,GP is expected
to be ﬁve times greater than Vmax,GS in the rabbit
heart. We assume that this relationship can be extra-
polated to the brain and set Vmax,GS accordingly. Km,GS
can be calculated to ensure a zero rate of change of
baseline glycogen for baseline glucose-6-phosphate
[G6P]a ¼ 0.7326 mM.
2.2. pH regulation model
The regulation of pH is modelled by introducing a buffer
solution composed of HCO
 
3 ,C O
2 
3 and H2CO3 inside
the cell and modelling the extrusion of H
þ ions outside
of the cell with two channels: MCT (the lactate-H
þ
co-transporter) and NHE (Na
þ/H
þ antiporter)
channels [16]:
CO2 þ H2O$
k1 H2CO3 $
k2 HCO
 
3 þ Hþ
and HCO
 
3 $
k3 CO
2 
3 þ Hþ;
9
=
;
ð2:4Þ
where ki are rate constants. Setting kfi and kbi to be the
forward and backward rate constants, respectively, from
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to intracellular [H
þ] is given by:
d½Hþ buffer
dt
¼ kf2½H2CO3  kb2½HCO
 
3  ½Hþ 
þ kf3½HCO
 
3   kb3½CO
2 
3  ½Hþ : ð2:5Þ
The initial concentrations of buffer components [13]
are given in table 1. kf1 ¼ 0.11 s
21 [33,34] and corre-
sponds to the slowest of the three reactions. kf2 is
large as it corresponds to a fast reaction [35]; thus kf2
is set to a high value of 1.0   10
4 s
21. kf3 is calculated
based on the formulae in Schultz et al. [36] and Roy
et al. [37]: kf3 ¼ 59.44/K2 with ln K2 ¼ a þ b/T þ g
ln T, where T is the temperature in Kelvin, a ¼
207.6548, b ¼ 211843.8 and g ¼ 233.6485. In our
case, temperature is assumed to be 310 K (378C).
Thus, kf3 ¼ 1.03   10
12 s
21. This makes the third reac-
tion in equation (2.5) essentially instantaneous. As kf2
and kf3 are much greater than kf1, kf3 is set at the
same order of magnitude as kf2, i.e. to 1.03   10
4 s
21.
Therefore, the rate at which the buffer responds to a
change of pH is governed by kf1. kbi rate constant
values are set so that the buffer solution is at equili-
brium for a pH of 7.2 using the following set of
equations:
kb1 ¼
kf1½CO2 
½H2CO3 
; kb2 ¼
kf2½H2CO3 
½HCO
 
3  ½Hþ 
and kb3 ¼
kf3½HCO
 
3  
½CO
2 
3  ½Hþ 
:
ð2:6Þ
To analyse CO2 dynamics, we follow the gas concen-
tration in both the capillary (CO2c) and in the space
comprising the neuron, the astrocyte and the extra-
cellular space (CO2t). We model the rate of change of
CO2t with
ð1   VcÞ 
dCO2t
dt
¼ Vnvnc CO2 þ Vgvgc CO2
 ð kCO2ðCO2t   CO2cÞÞ ð2:7Þ
where CO2 transport across the capillary wall is
kCO2(CO2t 2 CO2c) (i.e. linear mass transfer), the initial
value of CO2t is set to 2.5 mM (with a CO2cb a s e l i n e
value of 2.12 mM) and kCO2 ¼ 11:23s 1 is set to ensure
preservation of baseline values in the model. Vc, Vn
and Vg stand for the proportion of the space occupied
by the capillary, neuron and astrocyte compartments,
respectively, and vnc CO2 and vgc CO2 stand for the pro-
duction of CO2 by the neuron and astrocyte, respectively.
The expression for CO2c is modiﬁed to account for
the new transport model across the vessel wall and is
now given by:
dCO2c
dt
¼ð kCO2ðCO2t   CO2cÞÞ
  2:0  
Fin
Vc
 ð CO2c   CO2aÞ;
ð2:8Þ
where CO2a is the arterial CO2 concentration and Fin is
the capillary blood inﬂow.
We set the MCT and NHE channels to be responsible
for the direct transport of hydrogen outside of the cell and
Na
þ,C a
2þ,K
þ and Na
þ/Ca
2þ channels together with the
sodium–potassium pump to regulate the concentration of
Na
þ affecting the function of NHE, as shown in ﬁgure 2.
The MCT channel transports hydrogen at the same rate
as it does LAC [16]. The NHE antiporter transports
hydrogen at a rate depending on both pH and the differ-
ence between the extracellular and intracellular potassium
[16]. For one mole of Na
þ entering the cell, one mole of H
þ
is transported out. The pump is inactive for a pH above
7.2 and reaches maximal activity at 6.2 [38,39]. It obeys
Michaelis–Menten kinetics with respect to the Na
þ gradi-
ent. Therefore, we model the ﬂow equivalent current
through the channel by:
iNHE ¼
imaxð½Na e  ½ Na iÞ
Km þð ½ Na e  ½ Na iÞ
 
1
1 þ eaðpH 6:7Þ ; ð2:9Þ
where imax deﬁnes the maximal possible current
through the antiporter, Km is the Michaelis constant
and [Na]e and [Na]i are extracellular and intracellular
sodium concentrations, respectively. The ﬁrst term
Table 1. Added or modiﬁed parameters and initial conditions of the model. Parameters required for the modelling of pH buffer
behaviour are in the left column. Parameters required for the modelling of K
þ,N a
þ and Ca
2þ dynamics are given the right
column. Antiporter parameters are in the bottom left column.
parameter value parameter value
[HCO3
2]2 5 m M kK 49 202 pA
[CO3
22]5 0 mM kNa 5367.6 pA
[H2CO3] 1.5 mM kCa 327.25 pA
[H
þ] 63.1 nM kNaK 14.3383 pA
kf1 0.11 s
21 kNaCa 20.14 pA
kf2 1.00   10
4 s
21 [K]e 5.0 mM
kf3 1.03   10
4 s
21 [K]i 130 mM
kb1 183.33 s
21 [Na]e 140 mM
kb2 9508.7 M
21 s
21 [Na]i 19 mM
kb3 8.1616   10
10 M
21 s
21 [Ca]e 2.0023 mM
Km 23 mM [Ca]i 0.0006 mM
imax 10 pA x0 0.0012
h0 0.0401
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second for the change of the activity of the antiporter
with respect to pH.
According to Fuster et al. [39], the current through
NHE antiporters can range from 5 to 20 pA. Thus, we
choose a mid-range value for imax of 10 pA. We set
Km to 23 mM according to Helbig et al. [38]. iNHE can
be transformed into the rate of change of H
þ concen-
tration d[H
þ]NHE/dt by dividing iNHE by F   V, where
F is 96 485 C mol
21 and V is the cell volume, taken
here to be a constant value of 10   10
3mm
3. Thus,
including the contribution of MCT, NHE and the
buffer, equation (2.1) can be transformed into:
d½Hþ 
dt
¼ 
d½ATP 
dt
þ
d½LAC 
dt
þ
d½PCr 
dt
þ
d½Hþ buffer
dt
 
iNHE
FV
: ð2:10Þ
d[LAC]/dt corresponds to the difference between LAC
produced within the cell and LAC extruded through
the MCT. Ion transport affecting Na
þ concentrations is
modelled according to Endresen et al. [40]. To set the
concentrations of Na
þ,C a
2þ and K
þ at a steady state,
we ﬁrst assume a membrane potential of 269.8 mV,
which is achieved by adjusting the K
þ,N a
þ and Ca
2þ
in Endresen et al. [40] to values given in table 1.T h i sc a l -
culation was done with equation (A1) in appendix A of
Endresen et al. [40]. The values of kK,k Na, kCa,k NaK,
kNaCa and x0 and h0 parameters in equations (A3–A12)
of Endresen et al. [40] are set so that the rate of
change of ionic concentration and of parameters x and
h is 0. As there are ﬁve k values and three ionic rates
of change equations the system is underdetermined.
Thus, a positive value (with respect to current direction)
of 20 pA is set for iNaK which according to equation (A8)
leads to iK ¼ 10 pA. Furthermore, both iNa and iNaCa
need to be negative and have to satisfy equation (A10).
Thus, iNa is set to 215 pA, which leads to
iNaK ¼ 25 pA. With the values of the currents known
k values can be found directly from equations (A3–
A7). Finally, for the rates of change of x and h to be
equal to 0, the following two terms of equations (A11)
and (A12) need to be satisﬁed.
1
2
1 þ tanh
v   vx
kT=2e
     
  x0 ¼ 0
and
1
2
1   tanh
v   vx
kT=2e
     
  h0 ¼ 0;
ð2:11Þ
where v is the membrane potential, vx is 225.1 mV, k is
the Boltzmann constant and e is the elementary charge
and temperature T is 310.15 K. This enables the ATP
consumption dynamics to be modelled as described in
the next section.
2.3. ATP consumption modelling
The introduction of the NHE antiporter into the system
increases the cellular intake of Na
þ ions during ischae-
mia. This has to be reﬂected by the addition of the
current in equation (2.9) into equation (A 10). Further-
more, this additional ﬂow needs to be counterbalanced
by an increased activity of the sodium–potassium
pump. In the study of Cloutier et al. [30], the transport
through the pump is modelled with
Vpump ¼
Sm
V
  kpump  ½ ATP ½Na 
  1 þ
½ATP 
Km pump
    1
; ð2:12Þ
where Vpump is the rate of consumption of ATP in
mM s
21, Sm is the characteristic length equal to
40500 cm
21 for neurons and 10 500 cm
21 for astrocytes,
kpump is the transport rate constant equal to 3.17  
1027 cm mM
21 s
21 and Km_pump is the afﬁnity constant
equal to 0.4243 mM, V is a dimensionless constant
equal to 0.25 (astrocyte) or 0.45 (neuron) representing
the proportion of space occupied by the cell and [Na]
is the concentration of sodium in the cell.
In the study of Endresen et al. [40], the current
through the sodium–potassium pump is modelled by
iNaK ¼ kNaK tanh
v þ 2vK   3vNa   3vATP
2kT=e
  
; ð2:13Þ
where kNaK is a parameter introduced in the study of
Endresen et al. [40], v is the cell membrane potential,
vk and vNa are equilibrium potentials in mV for potas-
sium and sodium, respectively, and vATP is the free
energy associated with the breakdown of ATP. Both
currents depend on the intracellular concentration
of sodium and membrane potential; however, only
equation (2.12) depends on [ATP]. Therefore, equation
(2.13) is adjusted by including the terms which are
functions of [ATP] from equation (2.12). This gives
iNaK¼kNaK ks½ATP 
  1þ
½ATP 
Km pump
    1
tanh
vþ2vK 3vNa 3vATP
2kT=e
  
;
ð2:14Þ
Na+
H+
LAC
H+
K+
Na+
Ca2+
Na+ Ca2+
2K+
3Na+
MCT NHE
buffer
H+
LAC
CO2
Figure 2. Schematic representation of the model of intracellu-
lar pH regulation. H
þ transport channels are represented in
white. Other channels and pumps are represented in grey.
Arrows represent the direction of transport. Dotted arrows
represent production of a molecule. LAC stands for lactate.
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21 allowing iNaK to be
scaled to ensure that the value of the steady-state
current is the same as before the adjustment. The
steady-state value of [ATP] is 2.2592 mM for neurons
and 2.2400 mM for astrocytes. Substitution of values
leads to ks ¼ 2.799 mM
21 and ks ¼ 2.8033 mM
21 for
neurons and astrocytes, respectively. ATP consumption
of the sodium–potassium pump is set to be proportional
to that current.
3. NUMERICAL RESULTS
The CellML code for the Cloutier model (1 March 2010)
has been used as a base for implementation.
Modiﬁcations were included using the OPENCELL
v. 0.7 (University of Auckland, Auckland, NZ) soft-
ware. The Backward Euler algorithm was used for all
numerical simulations.
In order to simulate ischaemia CBF was reduced to
20 per cent of its initial value. In order to allow for
the stabilization of the system for baseline values,
CBF was changed according to the following switch
function:
CBFðtÞ¼CBF0   a   CBF0  
1
1 þ e 10ðt 50Þ ; ð3:1Þ
where CBF0 is the initial cerebral blood ﬂow, t is the
time in seconds from the beginning of the simulation
and a is a parameter between 0 and 1 representing
the magnitude of the fall of CBF. The variation of pH
and LAC as a function of time are shown in ﬁgure 3,
together with the change in the concentrations of
energy stores (i.e. ATP, PCr, glucose and glycogen)
and the change in the concentrations of intracellular
and extracellular sodium. The following properties of
the model are also reported: ﬁrst, that the fall of pH
is a linear function of decrease in CBF. Second, the
activity of the sodium–potassium pump is increased
by roughly 50 per cent during the ﬁrst 100 s and then
within 600 s it is decreased to roughly 125 per cent of
the baseline.
4. DISCUSSIONS
The results above have conﬁrmed the fall of pH after
CBF reduction, in agreement with the experimental lit-
erature. According to the study of Ljunggren et al. [41],
the expected fall of pH under total ischaemia is to
values of 6.6, 6.4 and 6.2 for hypo-, normo- and hyper-
glycaemic animals, respectively. Here, pH drops to a
value of between 6.8 and 6.9 for 80 per cent ischaemia
and given the near-linear relationship found between
pH and the level of ischaemia (not plotted here) it is
an encouraging agreement. After an initial drop of
pH, both the MCT and NHE contribute to the recovery
of baseline pH. This is possible because of the drop in
energy stores (i.e. a slower metabolism). The rate of
change of PCR reaches a minimal negative value
within 10 s from the drop of CBF and rises towards
zero quickly thereafter. The rate of change of LAC
(which is closely related to glucose consumption)
reaches its maximal value within 125 s from the drop
of CBF (ﬁgure 3). The combined effect allows main-
taining ATP at a baseline value for about 10 s after
CBF fall. Furthermore, with the fall of CBF, CO2 con-
centration increases with a gradually decreasing speed
rate. Its concentration increases from 2.5 mM to a pla-
teau at 6.1 in 1000 s. LAC and CO2 contribute to the
fall of pH, while PCr to its increase. PCR exceeds the
effect of LAC and CO2 for a few seconds which however,
does not allow to restore pH to its original 7.2 value.
The deeper the fall of pH is, the higher the activity of
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Figure 3. Variations of pH, intracellular LAC, CO2t, intracellular energy stores and sodium concentration as a function of time
after a CBF reduction of 80% of initial value. Where not mentioned plots are given for neurons.
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to clear the cell of excessive hydrogen ions and thus
the demand for ATP increases. As there is less ATP
soon comes the point when more LAC gets evacuated
from the cell by MCT than what gets produced in it
and thus the NHE can counterbalance the fall of pH
for as long as a substantial sodium gradient across the
cell wall is maintained. This gradient changes only by
around 15 per cent within the ﬁrst 3000 s from the
fall of CBF but begins to drop rapidly after this point.
Based on the above analysis, we may conclude that
the depth of fall of pH depends on the activity of the
LAC and NHE extruders and the ability to maintain
a high rate of glucose consumption. The critical par-
ameters for the determination of the depth of fall of
pH and its speed are therefore imax, which is reported
to vary between 5 and 20 pA (our setting is 10 pA);
thus potentially NHE can extrude H
þ at between half
and twice the current speed, and kf1, respectively.
The values of the reaction constants in equation (2.2)
are very high except for the constant kf1. According
tothestudyofKaila&Ransom[13]thehalf-timeofequi-
libration of the CO2 hydration–dehydration reaction
is roughly 15–30 s. Therefore, the kinetic difference
between cells containing, or not, carbon anhydrase (an
enzyme that catalyses carbon oxide hydration [13]) has
to be considered. An increase of the reaction speed may
lead to a more pronounced drop of pH. Results presented
in the study of Silver & Erecinska [42] suggest that the
fall of pH during ischaemia is in good agreement with
our predictions, as measurements of tissue pH after the
occlusion of the MCA in a rat model yielded a fall of
pH from 7.34 to 7.01 in 120 s and in our case a fall
from 7.20 to 7.00 in 125 s. Nevertheless, this feature of
the buffer may also have to be complemented with two
additional mechanisms. First, part of the buffering
power is also provided by means of imidazole groups on
the histidine residues of proteins or by the free and
bound forms of phosphate [43]. This buffering capacity
is comparable in magnitude to the CO2=HCO
 
3 buffer.
The intrinsic buffering capacity in neurons and glia
ranges between 10 and 20 mM [13], whereas the
CO2=HCO
 
3 buffer provides a capacity of 23 mM. Thus,
notonlyitisnotnegligiblebutalsohardtodeﬁneforapar-
ticular cell. Secondly, the CO2 may diffuse in the tissue
towards areas with a better perfusion. The diffusion
further increases the time in which CO2 reaches its
maximal concentration. Diffusion in the cellular micro-
environment in the brain has been well-characterized in
theliterature[44,45]andvaluesoftherequiredmodelpar-
ameters are well known. At the tissue scale, however, the
problem becomes numerically challenging with many
coupled partial differential equations. Open source tools
encouraged by the Virtual Physiological Human (VPH)
communityforreaction–diffusionproblems,likeFieldML
(University of Auckland, Auckland, NZ), are currently
under development [46–48]. In addition, commercial
packages like CFD-ACE (ESI-Group, Paris, France) are
available. An example of the methodology for dealing
with biologically driven spatio-temporal problems can be
found in the study of Lapin et al. [49].
In addition to the simulation of pH dynamics under
partial CBF reduction, it is also important to
understand that under the CBF ¼ 0 condition, the pH
drop is more signiﬁcant than for cells with perfusion.
The mechanism for H
þ generation in these cells differs
slightly from those with some residual perfusion. In case
of total ischaemia, the amount of H
þ that can be created
depends on how much glucose, glycogen PCr and ATP
wasinitiallyavailable.Thisisbecausemetabolicproducts
are not evacuated from the cell and its neighbourhood by
capillariesandthusallthatisconsumedwillremainthere
ordiffuse.JustlikeCO2,H
þdiffusesinthetissueandthus
tissuewith no perfusion may contribute to the damage in
its neighbourhood. This model will have to be expanded
to allow the simulation of this feature.
Further expansion of the model may have to include
additional pH regulation mechanisms like the Na
þ-
independent Cl
 =HCO
 
3 -exchange and NA
þ=HCO
 
3
co-transport [16,50,51] as they are not negligible. For
instance, the study of a guinea pig ventricular myocyte
showed that Na
þ/H
þ and NA
þ=HCO
 
3 have almost
equal contribution to acid extrusion [52]. As these
mechanisms are closely coupled with ionic concen-
trations inside and outside of the cell, it becomes
important to further follow the evolution of the
volume of the cell which alters these parameters [53].
A number of limitations of the present model have
been noted and modiﬁcations were proposed. The val-
idity and completeness of these choices will have to be
validated by comparison of simulation results with the
reported pH dynamics under ischaemia in animal
models like in the study of Silver & Erecinska [42]. Ide-
ally, this validation would be complemented with a
comparison of the model simulations with quantitative
pH and perfusion imaging data from an animal model.
Such a comparison should be made both at the core
of the induced infarct and in more distant brain
zones. Results would then help to show whether pH is
actually a valuable indicator of ﬁnal infarct size and
thus a potentially important clinical tool. In addition,
positive results would open two valuable research direc-
tions. First, the model could be extended to suit studies
focused on the use of hypothermia in stroke patients’
treatment. Hypothermia signiﬁcantly decreases cellular
metabolism and thus could increase the window of
opportunity for the injection of rt-PA and reduce
infarct size. A study of the effects of hypothermia
based on data from 3353 animals showed that the
infarct size can be reduced by 44 per cent (95% conﬁ-
dence interval 40–47%) [54]. Literature on both
cellular response to reduced temperature [55] and on
the dynamics of brain cooling [56,57] is available.
A recent review of the ﬁeld can be found in the study
of van der Worp et al. [58]. Second, low pH is believed
to contribute to the swelling of capillaries which
together with the mentioned earlier free radicals deliv-
ery leads to secondary tissue damage after
reperfusion. In the work of del Zoppo et al. [59], the
authors found 40 per cent of capillaries to be obstructed
after focal ischaemia with recirculation in a baboon.
Further details regarding secondary brain damage
after reperfusion can be found in the study of Trayst-
man et al. [19], Siesjo ¨ et al. [60,61] and Wang et al. [62].
In summary, this paper proposed a ﬁrst model of pH
dynamics in ischaemic brain cells. The pH system is
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Interface Focus (2011)very complex and the model needs furtheradjustment to
reproduce previously reported results. However, analysis
of the literature on the underlying physiology clearly
deﬁnes the improvements that have to be made. The
topics of interest include: metabolites diffusion in the
brain tissue, buffering with carbon anhydrase, metab-
olism under total ischaemia, cell volume regulation and
reﬁnement of pH regulation. Rapid advances in the
designoftoolssuchasFieldMLandquantitativepHima-
ging encourage further development of this model which
could contribute to quantitative decision support tools
for ischaemic stroke.
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